Literature DB >> 17499810

Effects of (-)-epigallocatechin-3-gallate in Ca2+ -permeable non-selective cation channels and voltage-operated Ca2+ channels in vascular smooth muscle cells.

Manuel Campos-Toimil1, Francisco Orallo2.   

Abstract

The effects of (-)-epigallocatechin-3-gallate (EGCG), the most abundant catechin of tea, on Ca(2+)-permeable non-selective cation currents (NSCC) and voltage-operated Ca(2+) channels (VOCC) have been investigated in cultured rat aortic smooth muscle cells using the whole-cell voltage-clamp technique. Under the Cs(+)/tetraethylammonium (TEA)-containing internal solution, and in the presence of nifedipine (1 microM), EGCG (30 microM) activated a long-lasting inward current, with a reversal potential (E(rev)) of approximately 0 mV. This current was not significantly altered by the replacement of [Cl(-)](i) or [Cl(-)](o), implying that the inward current was not a chloride channel, but a NSCC. SKF 96365 (30 microM) and Cd(2+) (500 microM) almost completely abolished the EGCG-induced NSCC. A higher dose of EGCG (100 microM) additionally activated a nifedipine-sensitive inward current in the absence of depolarization protocol. EGCG (100 microM) also potentiated a nifedipine-sensitive voltage-dependent Ba(2+)-current during the first 5 min of incubation. However, after > 10 min of incubation with EGCG, this current was significantly inhibited. Our results suggest that EGCG caused a Ca(2+) influx into smooth muscle cells via VOCC (probably L-type) and other SKF-96365- and Cd(2+)-sensitive Ca(2+)-permeable channels. The action described here may be responsible for the contraction induced by EGCG in rat aortic rings and for the rise of the intracellular concentration of Ca(2+) in rat aortic smooth muscle cells evoked by this catechin. On the other hand, the inhibition of VOCC after > 10 min of incubation may be, in part, responsible for the relaxation of rat aorta induced by EGCG.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499810     DOI: 10.1016/j.lfs.2007.04.005

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Epigallocatechin-3-gallate has dual, independent effects on the cardiac sarcoplasmic reticulum/endoplasmic reticulum Ca2+ ATPase.

Authors:  M E Kargacin; T L Emmett; Gary J Kargacin
Journal:  J Muscle Res Cell Motil       Date:  2011-08-05       Impact factor: 2.698

2.  Apigenin, a plant-derived flavone, activates transient receptor potential vanilloid 4 cation channel.

Authors:  Xin Ma; Dongxu He; Xiaochen Ru; Yun Chen; Yanfei Cai; Iain C Bruce; Qiang Xia; Xiaoqiang Yao; Jian Jin
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Inhibition of the intracellular Ca(2+) transporter SERCA (Sarco-Endoplasmic Reticulum Ca(2+)-ATPase) by the natural polyphenol epigallocatechin-3-gallate.

Authors:  Fernando Soler; M Carmen Asensio; Francisco Fernández-Belda
Journal:  J Bioenerg Biomembr       Date:  2012-08-01       Impact factor: 2.945

4.  Endothelial NO Production Is Mandatory for Epigallocatechin-3-Gallate-induced Vasodilation: Results From eNOS Knockout (eNOS-/-) Mice.

Authors:  Mario Lorenz; Laura Klinkner; Gert Baumann; Karl Stangl; Verena Stangl
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

Review 5.  Vasodilator compounds derived from plants and their mechanisms of action.

Authors:  Francisco J Luna-Vázquez; César Ibarra-Alvarado; Alejandra Rojas-Molina; Isela Rojas-Molina; Miguel Angel Zavala-Sánchez
Journal:  Molecules       Date:  2013-05-17       Impact factor: 4.411

Review 6.  Flavonoids in Treatment of Chronic Kidney Disease.

Authors:  Yi-Ling Cao; Ji-Hong Lin; Hans-Peter Hammes; Chun Zhang
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

Review 7.  Potential Benefits of Flavonoids on the Progression of Atherosclerosis by Their Effect on Vascular Smooth Muscle Excitability.

Authors:  Rosa Edith Grijalva-Guiza; Aura Matilde Jiménez-Garduño; Luis Ricardo Hernández
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.